Psychiatry and Neurology, Neurology · Forest Hills, NY
NPI
1124013990
Since 2005
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
10124 Queens Blvd, Suite A
Forest Hills, NY, 11375
Phone (718) 261-8881
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.2M
63,444 services
Medicare patients, 2024
1,079
Average age 77
Drug cost, 2024
$8.0M
17,673 prescriptions
Company payments, 2025
$3,468
From 29 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Marina Neystat was code J0585 (injection, onabotulinumtoxina, 1 unit), 53,140 times for 95 patients. In total Marina Neystat billed 63,444 services in 64 codes, and Medicare paid $1.2M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-06-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 53,140 | 95 | $4.92 | $262K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 2,183 | 349 | $59.50 | $130K |
| 99214 Office E&M - Established | Office | 1,181 | 544 | $117.69 | $139K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 669 | 217 | $46.37 | $31K |
| 99213 Office E&M - Established | Office | 651 | 394 | $81.95 | $53K |
| 95886 Electrical Nerve Conductivity | Office | 536 | 263 | $93.20 | $50K |
| J3475 Injection, magnesium sulfate, per 500 mg | Office | 510 | 195 | $0.44 | $224 |
| 96374 Injection Administration | Office | 491 | 198 | $35.58 | $17K |
| 99204 Office E&M - New | Office | 278 | 277 | $158.69 | $44K |
| 95911 Electrical Nerve Conductivity | Office | 267 | 262 | $204.66 | $55K |
| 95819 Neurologic | Office | 247 | 245 | $454.38 | $112K |
| 64615 Musculoskeletal | Office | 234 | 84 | $151.05 | $35K |
| 92540 Vision, Hearing, and Speech Services | Office | 184 | 182 | $100.19 | $18K |
| 92547 Vision, Hearing, and Speech Services | Office | 184 | 182 | $10.61 | $1,952 |
| 92537 Test - Miscellaneous | Office | 184 | 182 | $37.56 | $6,912 |
By year: 2022 $1.3M for 66,700 services; 2023 $1.1M for 60,379 services; 2024 $1.2M for 63,444 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 30 | 29 | $8.65 | $260 |
Medicare prescription drug claims, 2024
In 2024, the drug Marina Neystat prescribed most often to Medicare patients was Duloxetine Hcl, with 1,098 prescriptions and refills. In total Marina Neystat wrote 17,673 Medicare prescriptions that cost $8.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Duloxetine Hcl Generic | 1,098 | 1,230 | 190 | $14K |
| Memantine Hcl Er Memantine Hcl | 744 | 879 | 133 | $46K |
| Gabapentin Generic | 646 | 718 | 162 | $4,571 |
| Nurtec Odt Rimegepant Sulfate | 642 | 652 | 120 | $830K |
| Horizant Gabapentin Enacarbil | 554 | 559 | 78 | $337K |
| Escitalopram Oxalate Generic | 543 | 626 | 95 | $2,033 |
| Diclofenac Sodium Generic | 532 | 554 | 98 | $288K |
| Memantine Hcl Generic | 466 | 541 | 79 | $6,342 |
| Trazodone Hcl Generic | 406 | 442 | 89 | $1,349 |
| Ztlido Lidocaine | 353 | 359 | 75 | $130K |
| Gralise Gabapentin | 353 | 387 | 56 | $200K |
| Namzaric Memantine Hcl/Donepezil Hcl | 328 | 366 | 49 | $207K |
| Meloxicam Generic | 299 | 305 | 159 | $585 |
| Qulipta Atogepant | 296 | 302 | 54 | $316K |
| Trintellix Vortioxetine Hydrobromide | 285 | 311 | 48 | $147K |
Brand drugs: - claims; generic drugs: 11,354 claims; opioid claims: 148.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Marina Neystat $3,468 ($3,468 in general payments such as food, travel and fees) from 29 companies. The largest payer was Abbvie Inc. with $541.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.